The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection
Open accessAbstract
Extended-spectrum β-lactamase (ESBL)-producing Gram-negative pathogens are a major cause of resistance to expanded-spectrum β-lactam antibiotics. Since their discovery in the early 1980s, they have spread worldwide and an are now endemic in Enterobacterales isolated from both hospital-associated and community-acquired infections. As a result, they are a global public health concern. In the past, TEM- and SHV-type ESBLs were the predominant families of ESBLs. Today CTX-M-type enzymes are the most commonly found ESBL type with the CTX-M-15 variant dominating worldwide, followed in prevalence by CTX-M-14, and CTX-M-27 is emerging in certain parts of the world. The genes encoding ESBLs are often found on plasmids and harboured within transposons or insertion sequences, which has enabled their spread. In addition, the population of ESBL-producing Escherichia coli is dominated globally by a highly virulent and successful clone belonging to ST131. Today, there are many diagnostic tools available to the clinical microbiology laboratory and include both phenotypic and genotypic tests to detect β-lactamases. Unfortunately, when ESBLs are not identified in a timely manner, appropriate antimicrobial therapy is frequently delayed, resulting in poor clinical outcomes. Several analyses of clinical trials have shown mixed results with regards to whether a carbapenem must be used to treat serious infections caused by ESBLs or whether some of the older β-lactam-β-lactamase combinations such as piperacillin/tazobactam are appropriate. Some of the newer combinations such as ceftazidime/avibactam have demonstrated efficacy in patients. ESBL-producing Gram-negative pathogens will continue to be major contributor to antimicrobial resistance worldwide. It is essential that we remain vigilant about identifying them both in patient isolates and through surveillance studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast, scalable generation of high‐quality protein multiple sequence alignments using Clustal Omega
Sievers, F., Wilm, A., Dineen, D., Gibson, T. J., Karplus, K., Li, W., Lopez, R., McWilliam, H., Remmert, M., Söding, J., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.75 · Cited by 15,355
The EMBL-EBI search and sequence analysis tools APIs in 2019
Madeira, F., Park, Y. M., Lee, J., Buso, N., Gur, T., Madhusoodanan, N., Basutkar, P., Tivey, A. R. N., Potter, S. C., Finn, R. D., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz268 · Cited by 4,167
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Mobile Genetic Elements Associated with Antimicrobial Resistance
Partridge, S. R., Kwong, S. M., Firth, N., & Jensen, S. O. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00088-17 · Cited by 2,751
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
Self-citationA functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
A new bioinformatics analysis tools framework at EMBL-EBI
Goujon, M., McWilliam, H., Li, W., Valentin, F., Squizzato, S., Paern, J., & Lopez, R. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq313 · Cited by 1,846
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,147
Epidemiology of β-Lactamase-Producing Pathogens
Bush, K., & Bradford, P. A. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-19 · Cited by 938
Self-citationCTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Escherichia coli ST131, an Intriguing Clonal Group
Nicolas-Chanoine, M.-H., Bertrand, X., & Madec, J.-Y. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00125-13 · Cited by 895
Evans, B. A., & Amyes, S. G. B. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-13 · Cited by 815
Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe
Coque, T. M., Baquero, F., & Cantón, R. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19044-en · Cited by 799
Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype
Bevan, E. R., Jones, A. M., & Hawkey, P. M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx146 · Cited by 791
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
Harris, P. N. A., Tambyah, P. A., Lye, D. C., Mo, Y., Lee, T. H., Yilmaz, M., Alenazi, T. H., Arabi, Y., Falcone, M., Bassetti, M., et al. (2018) · JAMA · doi:10.1001/jama.2018.12163 · Cited by 774
Rodríguez-Baño, J., Gutiérrez-Gutiérrez, B., Machuca, I., & Pascual, A. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00079-17 · Cited by 704
Coque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070350 · Cited by 702
Woerther, P.-L., Burdet, C., Chachaty, E., & Andremont, A. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-13 · Cited by 686
IS CR Elements: Novel Gene-Capturing Systems of the 21st Century?
Toleman, M. A., Bennett, P. M., & Walsh, T. R. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00048-05 · Cited by 587
Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017.
Jernigan, J. A., Hatfield, K. M., Wolford, H., Nelson, R. E., Olubajo, B., Reddy, S. C., McCarthy, N., Paul, P., McDonald, L. C., Kallen, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914433 · Cited by 577
Penicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae
DATTA, N., & KONTOMICHALOU, P. (1965) · Nature · doi:10.1038/208239a0 · Cited by 569
Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653932 · Cited by 510
Self-citationThe spread of CTX-M-type extended-spectrum β-lactamases
Rossolini, G. M., D'Andrea, M. M., & Mugnaioli, C. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01867.x · Cited by 487
Wiener, J. (1999) · JAMA · doi:10.1001/jama.281.6.517 · Cited by 485
Bradford, P. A., Bratu, S., Urban, C., Visalli, M., Mariano, N., Landman, D., Rahal, J. J., Brooks, S., Cebular, S., & Quale, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421495 · Cited by 485
Self-citationTamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1478 · Cited by 441
Poirel, L., Le Thomas, I., Naas, T., Karim, A., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.622-632.2000 · Cited by 421
Bush, K., & Fisher, J. F. (2011) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090110-102911 · Cited by 419
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab295 · Cited by 390
Zhanel, G. G., Lawrence, C. K., Adam, H., Schweizer, F., Zelenitsky, S., Zhanel, M., Lagacé-Wiens, P. R. S., Walkty, A., Denisuik, A., Golden, A., et al. (2018) · Drugs · doi:10.1007/s40265-017-0851-9 · Cited by 377
A new plasmidic cefotaximase in a clinical isolate of Escherichia coli
Bauernfeind, A., Schweighart, S., & Grimm, H. (1990) · Infection · doi:10.1007/bf01647010 · Cited by 363
Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147
Peirano, G., Chen, L., Kreiswirth, B. N., & Pitout, J. D. D. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01148-20 · Cited by 363
Poirel, L., Decousser, J.-W., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2938-2945.2003 · Cited by 357
β-Lactamases of Kluyvera ascorbata , Probable Progenitors of Some Plasmid-Encoded CTX-M Types
Humeniuk, C., Arlet, G., Gautier, V., Grimont, P., Labia, R., & Philippon, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3045-3049.2002 · Cited by 338
DNA sequence analysis of the genetic environment of various blaCTX-M genes
Eckert, C., Gautier, V., & Arlet, G. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki398 · Cited by 331
Peirano, G., & Pitout, J. D. D. (2019) · Drugs · doi:10.1007/s40265-019-01180-3 · Cited by 328
Knox, J. R. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.12.2593 · Cited by 311
The continuing challenge of ESBLs
PEREZ, F., ENDIMIANI, A., HUJER, K., & BONOMO, R. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.08.003 · Cited by 298
Prevalence and clonality of extended-spectrum β-lactamases in Asia
Hawkey, P. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01855.x · Cited by 289
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf240 · Cited by 284
Murphy, C. N., Fowler, R., Balada-Llasat, J. M., Carroll, A., Stone, H., Akerele, O., Buchan, B., Windham, S., Hopp, A., Ronen, S., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00128-20 · Cited by 269
A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131
Banerjee, R., & Johnson, J. R. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02824-14 · Cited by 268
Poirel, L., Kämpfer, P., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.4038-4040.2002 · Cited by 266
The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world
Doi, Y., Iovleva, A., & Bonomo, R. A. (2017) · Journal of Travel Medicine · doi:10.1093/jtm/taw102 · Cited by 248
A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous
Liakopoulos, A., Mevius, D., & Ceccarelli, D. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01374 · Cited by 239
Escherichia coli ST131- H 22 as a Foodborne Uropathogen
Liu, C. M., Stegger, M., Aziz, M., Johnson, T. J., Waits, K., Nordstrom, L., Gauld, L., Weaver, B., Rolland, D., Statham, S., et al. (2018) · mBio · doi:10.1128/mbio.00470-18 · Cited by 239
Poirel, L., Menuteau, O., Agoli, N., Cattoen, C., & Nordmann, P. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3542-3547.2003 · Cited by 235
Lewis, J. S., Herrera, M., Wickes, B., Patterson, J. E., & Jorgensen, J. H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00576-07 · Cited by 231
GES-2, a Class A β-Lactamase from Pseudomonas aeruginosa with Increased Hydrolysis of Imipenem
Poirel, L., Weldhagen, G. F., Naas, T., De Champs, C., Dove, M. G., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2598-2603.2001 · Cited by 228
Hilty, M., Betsch, B. Y., Bögli-Stuber, K., Heiniger, N., Stadler, M., Küffer, M., Kronenberg, A., Rohrer, C., Aebi, S., Endimiani, A., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis581 · Cited by 226
Poirel, L., Naas, T., Guibert, M., Chaibi, E. B., Labia, R., & Nordmann, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.573 · Cited by 224
Defining an extended-spectrum β-lactamase
Livermore, D. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01857.x · Cited by 222
Minor extended-spectrum β-lactamases
Naas, T., Poirel, L., & Nordmann, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01861.x · Cited by 214
Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'
Bush, K. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.3.264 · Cited by 211
Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa
Nordmann, P., Ronco, E., Naas, T., Duport, C., Michel-Briand, Y., & Labia, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.962 · Cited by 201
Harris, P. N. A., Tambyah, P. A., & Paterson, D. L. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70950-8 · Cited by 198
Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27Gene
Matsumura, Y., Pitout, J. D. D., Gomi, R., Matsuda, T., Noguchi, T., Yamamoto, M., Peirano, G., DeVinney, R., Bradford, P. A., Motyl, M. R., et al. (2016) · Emerging Infectious Diseases · doi:10.3201/eid2211.160519 · Cited by 187
Self-citationLartigue, M.-F., Poirel, L., Aubert, D., & Nordmann, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1282-1286.2006 · Cited by 180
Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam
Reuland, E. A., al Naiemi, N., Kaiser, A. M., Heck, M., Kluytmans, J. A. J. W., Savelkoul, P. H. M., Elders, P. J. M., & Vandenbroucke-Grauls, C. M. J. E. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv441 · Cited by 170
MEDEIROS, A. A. (1984) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071942 · Cited by 164
Clinical significance of extended-spectrum β-lactamases
Rodríguez-Baño, J., & Pascual, A. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.671 · Cited by 163
McDanel, J. S., Schweizer, M. L., Crabb, V., Nelson, R. E., Samore, M. H., Khader, K., Blevins, A., Diekema, D. J., Chiang, H., Nair, R., et al. (2017) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2017.156 · Cited by 161
Henderson, A., Paterson, D. L., Chatfield, M. D., Tambyah, P. A., Lye, D. C., De, P. P., Lin, R. T. P., Chew, K. L., Yin, M., Lee, T. H., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1479 · Cited by 161
Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases
Marcadé, G., Deschamps, C., Boyd, A. C., Gautier, V., Picard, B., Branger, C., Denamur, É., & Arlet, G. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn428 · Cited by 155
Poirel, L., Castanheira, M., Carrër, A., Rodriguez, C. P., Jones, R. N., Smayevsky, J., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00022-11 · Cited by 155
Self-citationChen, Y., Delmas, J., Sirot, J., Shoichet, B. K., & Bonnet, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.02.010 · Cited by 154
Bauernfeind, A., Stemplinger, I., Jungwirth, R., Mangold, P., Amann, S., Akalın, E., Anğ, Ö., Bal, Ç., & Casellas, J. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.616 · Cited by 153
Effect of D240G substitution in a novel ESBL CTX-M-27
Bonnet, R., Recule, C., Baraduc, R., Chanal, C., Sirot, D., Champs, C. D., & Sirot, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg256 · Cited by 152
Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods
Poirel, L., Bonnin, R. A., & Nordmann, P. (2012) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2012.02.008 · Cited by 146
Dudley, M. N., Ambrose, P. G., Bhavnani, S. M., Craig, W. A., Ferraro, M. J., & Jones, R. N. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit017 · Cited by 139
Decousser, J., Poirel, L., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3595-3598.2001 · Cited by 136
Rodríguez, M. M., Power, P. P., Radice, M. A., Vay, C. A., Famiglietti, A. M. R., Galleni, M., Ayala, J. A., & Gutkind, G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4895-4897.2004 · Cited by 133
Blanco, J., Mora, A., Mamani, R., Lopez, C., Blanco, M., Dahbi, G., Herrera, A., Blanco, J. E., Alonso, M. P., García-Garrote, F., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr235 · Cited by 133
Rapid Detection of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Nordmann, P., Dortet, L., & Poirel, L. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00859-12 · Cited by 131
Perilli, M., Dell’Amico, E., Segatore, B., Massis, M. R. D., Bianchi, C., Luzzaro, F., Rossolini, G. M., Toniolo, A., Nicoletti, G., & Amicosante, G. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.2.611-614.2002 · Cited by 131
Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals
Celenza, G., Pellegrini, C., Caccamo, M., Segatore, B., Amicosante, G., & Perilli, M. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl055 · Cited by 130
Jacoby, G. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1123-1129.2006 · Cited by 129
In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters
Mushtaq, S., Warner, M., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq306 · Cited by 129
Popejoy, M. W., Paterson, D. L., Cloutier, D. J., Huntington, J. A., Miller, B. W., Bliss, C. A., Steenbergen, J. N., Hershberger, E., Umeh, O., & Kaye, K. S. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw374 · Cited by 129
Ford, P. J., & Avison, M. B. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh251 · Cited by 127
Redefining extended-spectrum -lactamases: balancing science and clinical need
Giske, C. G., Sundsfjord, A., Kahlmeter, G., Woodford, N., Nordmann, P., Paterson, D. L., Cantón, R., & Walsh, T. R. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn444 · Cited by 124
Picão, R. C., Poirel, L., Gales, A. C., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00453-09 · Cited by 124
Livermore, D. M., Day, M. J., Cleary, P. R., Hopkins, K. L., Toleman, M. A., Wareham, D. W., Wiuff, C., Doumith, M., & Woodford, N. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky453 · Cited by 124
Genetic support of extended-spectrum β-lactamases
Poirel, L., Naas, T., & Nordmann, P. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01865.x · Cited by 118
Huletsky, A., Knox, J. R., & Lévesque, R. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53748-0 · Cited by 116
Tschudin‐Sutter, S., Lucet, J., Mutters, N. T., Tacconelli, E., Zahar, J., & Harbarth, S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix258 · Cited by 116
IRT and CMT β-lactamases and inhibitor resistance
Cantón, R., Morosini, M.-I., Martin, O., de la Maza, S., & de la Pedrosa, E. G. G. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01849.x · Cited by 115
Aubert, D., Poirel, L., Chevalier, J., Léotard, S., Pagès, J., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1615-1620.2001 · Cited by 115
Peirano, G., Richardson, D. C., Nigrin, J., McGeer, A., Loo, V. G., Toye, B., Alfa, M. J., Pienaar, C., Kibsey, P., & Pitout, J. D. D. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01338-09 · Cited by 113
Partridge, S. R., Zong, Z., & Iredell, J. R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00025-11 · Cited by 111
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases
Walther‐Rasmussen, J., & Høiby, N. (2004) · Canadian Journal of Microbiology · doi:10.1139/w03-111 · Cited by 110
Kohira, N., Hackel, M., Ishioka, Y., Kuroiwa, M., Sahm, D. F., Sato, T., Maki, H., & Yamano, Y. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.07.009 · Cited by 110
Billard‐Pomares, T., Fouteau, S., Jacquet, M. E., Roche, D., Barbe, V., Castellanos, M., Bouet, J., Cruveiller, S., Médigue, C., Blanco, J., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03183-14 · Cited by 107
Oliver, A., Pérez-Díaz, J. C., Coque, T. M., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.616-620.2001 · Cited by 107
Sader, H. S., Rhomberg, P. R., Flamm, R. K., Jones, R. N., & Castanheira, M. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx050 · Cited by 106
Self-citationPitout, J. D. D., Laupland, K. B., Church, D. L., Menard, M. L., & Johnson, J. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4667-4670.2005 · Cited by 105
de Santi, M. P., Casella, T., Oliveira, M. G. D. L., Rubio, F. G., Nogueira, M. L., de Almeida, M. T. G., & Nogueira, M. C. L. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-176 · Cited by 104
Tchesnokova, V. L., Rechkina, E., Larson, L., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy525 · Cited by 104
Sun, T., Nukaga, M., Mayama, K., Braswell, E. H., & Knox, J. R. (2003) · Protein Science · doi:10.1110/ps.0224303 · Cited by 102
Evolution of Transposons Containing bla TEM Genes
Partridge, S. R., & Hall, R. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1267-1268.2005 · Cited by 101
A 1998 Survey of Extended-Spectrum β-Lactamases in Enterobacteriaceae in France
de Champs, C., Sirot, D., Chanal, C., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3177-3179.2000 · Cited by 100
Giakkoupi, P., TZOUVELEKIS, L. S., Tsakris, A., Loukova, V., Sofianou, D., & Tzelepi, Ε. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2247-2253.2000 · Cited by 100
Six Groups of the OXY β-Lactamase Evolved over Millions of Years in Klebsiella oxytoca
Fèvre, C., Jbel, M., Passet, V., Weill, F., Grimont, P. A. D., & Brisse, S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3453-3462.2005 · Cited by 100
Courpon-Claudinon, A., Lefort, A., Panhard, X., Clermont, O., Dornic, Q., Fantin, B., Mentré, F., Wolff, M., Denamur, É., & Branger, C. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03298.x · Cited by 95
Johnson, T. J., Elnekave, E., Miller, E. A., Muñoz-Aguayo, J., Flores-Figueroa, C., Johnston, B., Nielson, D. W., Logue, C. M., & Johnson, J. R. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01913-18 · Cited by 92
Spanu, T., Sanguinetti, M., Tumbarello, M., D’Inzeo, T., Fiori, B., Posteraro, B., Santangelo, R., Cauda, R., & Fadda, G. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00433-06 · Cited by 88
Blanco, J., Mora, A., Mamani, R., López, C., Blanco, M., Dahbi, G., Herrera, A., Marzoa, J., Fernández, V., de la Cruz, F., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01555-13 · Cited by 88
Castanheira, M., Mendes, R. E., Rhomberg, P. R., & Jones, R. N. (2008) · Microbial Drug Resistance · doi:10.1089/mdr.2008.0827 · Cited by 88
Self-citationYoon, E.-J., & Jeong, S. H. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa513 · Cited by 87
Dortet, L., Oueslati, S., Jeannot, K., Tandé, D., Naas, T., & Nordmann, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05058-14 · Cited by 85
Rojas, L. J., Weinstock, G. M., Cadena, E. D. L., Díaz, L., Ríos, R., Hanson, B., Brown, J. S., Vats, P., Phillips, D. S., Nguyen, H. T., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix524 · Cited by 83
Vahaboğlu, H., Öztürk, R., Özinel, M. A., Kocazeybek, B. S., Sahin, N., Korten, V., Tansel, Ö., Akalın, H., Tatman‐Otkun, M., Köksal, İ., et al. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-7-642 · Cited by 72
Kaye, K. S., Gold, H. S., Schwaber, M. J., Venkataraman, L., Qi, Y., Girolami, P. C. D., Samore, M. H., Anderson, G., Rasheed, J. K., & Tenover, F. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1520-1525.2004 · Cited by 71
Rodriguez‐Villalobos, H., Bogaerts, P., Berhin, C., Bauraing, C., Deplano, A., Montesinos, I., Mendonça, R. D., Jans, B., & Glupczynski, Y. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq388 · Cited by 70
Multicenter Evaluation of the Unyvero Platform for Testing Bronchoalveolar Lavage Fluid
Klein, M., Bacher, J., Barth, S., Atrzadeh, F., Siebenhaller, K., Ferreira, I. M., Beisken, S., Posch, A. E., Carroll, K. C., Wunderink, R. G., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.02497-20 · Cited by 70
Direct involvement of IS26 in an antibiotic resistance operon
Lee, K. Y., Hopkins, J. D., & Syvanen, M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.6.3229-3236.1990 · Cited by 68
Peirano, G., Sang, J. H. K., Pitondo‐Silva, A., Laupland, K. B., & Pitout, J. D. D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks026 · Cited by 68
Palacios-Baena, Z. R., Gutiérrez‐Gutiérrez, B., de Cueto, M., Viale, P., Venditti, M., Hernández‐Torres, A., Oliver, A., Martı́nez-Martı́nez, L., Calbo, E., Pintado, V., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw513 · Cited by 65
Renvoisé, A., Decré, D., Amarsy, R., Huang, T., Jost, C., Podglajen, I., Raskine, L., Genel, N., Bogaerts, P., Jarlier, V., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01936-13 · Cited by 64
Nakamura, K., Kaneko, M., ABE, Y., Yamamoto, N., Mori, H., Yoshida, A., Ohashi, K., Miura, S., Yang, T.-C., Momoi, N., et al. (2015) · Journal of Hospital Infection · doi:10.1016/j.jhin.2015.05.002 · Cited by 62
Tamma, P. D., Sharara, S. L., Pana, Z. D., Amoah, J., Fisher, S. L., Tekle, T., Doi, Y., & Simner, P. J. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz353 · Cited by 60
Self-citationCastanheira, M., Costello, S. E., Woosley, L. N., Deshpande, L. M., Davies, T. A., & Jones, R. N. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03930-14 · Cited by 59
Self-citationBernabeu, S., Ratnam, K. C., Boutal, H., Gonzalez, C., Vogel, A., Devilliers, K., Plaisance, M., Oueslati, S., Malhotra‐Kumar, S., Dortet, L., et al. (2020) · Diagnostics · doi:10.3390/diagnostics10100764 · Cited by 59
Mendes, R. E., Jones, R. N., Woosley, L. N., Cattoir, V., & Castanheira, M. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz004 · Cited by 58
Self-citationRood, I. G. H., & Li, Q. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.07.013 · Cited by 57
Castanheira, M., Mendes, R. E., Walsh, T. R., Gales, A. C., & Jones, R. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2344-2345.2004 · Cited by 56
Self-citationCastanheira, M., Doyle, T. B., Smith, C. J., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz243 · Cited by 56
Self-citationCastanheira, M., Mendes, R. E., Jones, R. N., & Sader, H. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00540-16 · Cited by 55
Self-citationXia, L., Liu, Y., Xia, S., Kudinha, T., Xiao, S.-N., Zhong, N., Ren, G.-S., & Zhuo, C. (2017) · Scientific Reports · doi:10.1038/srep44866 · Cited by 55
Tamma, P. D., Smith, T. T., Adebayo, A., Karaba, S. M., Jacobs, E. B., Wakefield, T., Nguyen, T. H. D., Whitfield, N. N., & Simner, P. J. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00127-21 · Cited by 52
Self-citationMantengoli, E., & Rossolini, G. M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3289-3296.2005 · Cited by 51
Transposition of the gene encoding a TEM-12 extended-spectrum beta-lactamase
Heritage, J. C., Hawkey, P. M., Todd, N. J., & Lewis, I. J. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1981 · Cited by 50
Investigation of diversity of plasmids carrying the blaTEM-52 gene
Bielak, E. M., Bergenholtz, R. D., Jørgensen, M. S., Sørensen, S. J., Hansen, L. H., & Hasman, H. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr331 · Cited by 49
Peirano, G., Lynch, T., Matsumara, Y., Nóbrega, D. B., Finn, T. J., DeVinney, R., & Pitout, J. D. D. (2020) · Emerging infectious diseases · doi:10.3201/eid2612.201221 · Cited by 45
Genetic Features of CTX-M-15-Producing Acinetobacter baumannii from Haiti
Potron, A., Munoz-Price, L. S., Nordmann, P., Cleary, T., & Poirel, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05124-11 · Cited by 44
Valenza, G., Werner, M., Eisenberger, D., Nickel, S., Lehner-Reindl, V., Höller, C., & Bogdan, C. (2019) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2019.01.014 · Cited by 38
Flament-Simon, S.-C., García, V., Duprilot, M., Mayer, N., Alonso, M. P., García‐Meniño, I., Blanco, J. E., Blanco, M., Nicolas-Chanoine, M.-H., & Blanco, J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00125 · Cited by 38
SHV-49, a Novel Inhibitor-Resistant β-Lactamase in a Clinical Isolate of Klebsiella pneumoniae
Dubois, V., Poirel, L., Arpin, C., Coulange, L., Bébéar, C., Nordmann, P., & Quentin, C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4466-4469.2004 · Cited by 36
Robin, F., Delmas, J., Schweitzer, C., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01058-06 · Cited by 33
In Vitro Prediction of the Evolution of GES-1 β-Lactamase Hydrolytic Activity
Bontron, S., Poirel, L., & Nordmann, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04450-14 · Cited by 31
Morosini, M. I., García-Castillo, M., Tato, M., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03614-13 · Cited by 30
Distinction entre les structures primaires des β-lactamases TEM-1 et TEM-2
Barthélémy, M., Péduzzi, J., & Labia, R. (1985) · Research in Microbiology · doi:10.1016/s0769-2609(85)80093-4 · Cited by 30
Dubois, V., Poirel, L., Demarthe, F., Arpin, C., Coulange, L., Minarini, L. A. D. R., Bezian, M. C., Nordmann, P., & Quentin, C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00387-08 · Cited by 28
Mendes, R. E., Castanheira, M., Woosley, L. N., Stone, G. G., Bradford, P. A., & Flamm, R. K. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02655-18 · Cited by 28
Self-citationTamma, P. D., & Humphries, R. M. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab019 · Cited by 28
Zeil, C., Widmann, M., Fademrecht, S., Vogel, C., & Pleiss, J. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02930-15 · Cited by 27
Rodríguez‐Baño, J., Gutiérrez‐Gutiérrez, B., & Pascual, Á. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa112 · Cited by 27
The blaSHV-5 gene is encoded in a compound transposon duplicated in tandem in Enterobacter cloacae
Garza–Ramos, U., Dávila, G., González, V., Alpuche-Aranda, C. M., López-Collada, V. R., Alcántar-Curiel, M. D., Newton, O., & Silva-Sánchez, J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02790.x · Cited by 25
Comment on: Redefining extended-spectrum -lactamases: balancing science and clinical need
Bush, K., Jacoby, G. A., Amicosante, G., Bonomo, R. A., Bradford, P. A., Cornaglia, G., Garau, J., Giamarellou, H., Jarlier, V., Martı́nez-Martı́nez, L., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp104 · Cited by 21
Self-citationCON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales
Mathers, A. J., & Lewis, J. S. (2021) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlab020 · Cited by 21
El-Jade, M. R., Parčina, M., Schmithausen, R. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160203 · Cited by 20
Neubauer, S., Madzgalla, S., Marquet, M., Klabunde, A., Büttner, B., Göhring, A., Brandt, C., Feller, K. ‐., Pletz, M. W., & Makarewicz, O. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02293-19 · Cited by 18
Royer, G., Fourreau, F., Boulanger, B., Mercier-Darty, M., Ducellier, D., Cizeau, F., Potron, A., Podglajen, I., Mongardon, N., & Decousser, J. (2019) · Journal of Hospital Infection · doi:10.1016/j.jhin.2019.07.014 · Cited by 17
Cited by
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac268 · Cited by 526
Urinary Tract Infections: The Current Scenario and Future Prospects
Mancuso, G., Midiri, A., Gerace, E., Marra, M., Zummo, S., & Biondo, C. (2023) · Pathogens · doi:10.3390/pathogens12040623 · Cited by 396
Elfadadny, A., Ragab, R. F., AlHarbi, M., Badshah, F., Ibáñez-Arancibia, E., Farag, A., Hendawy, A. O., De los Ríos-Escalante, P. R., Aboubakr, M., Zakai, S. A., et al. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374466 · Cited by 340
Metadata
- Authors
- Castanheira, M., Simner, P. J., & Bradford, P. A.
- Venue
- JAC-Antimicrobial Resistance
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-07-12
- Volume
- 3
- Issue
- 3
- Pages
- dlab092-dlab092
- ISSN
- 2632-1823 (ISSN-L)
- OpenAlex
- W3184815473
- Cited by
- 796
- References
- 158
- FWCI
- 29.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.